Literature DB >> 15746101

Crystal structures of the RNA-dependent RNA polymerase genotype 2a of hepatitis C virus reveal two conformations and suggest mechanisms of inhibition by non-nucleoside inhibitors.

Bichitra K Biswal1, Maia M Cherney, Meitian Wang, Laval Chan, Constantin G Yannopoulos, Darius Bilimoria, Olivier Nicolas, Jean Bedard, Michael N G James.   

Abstract

Crystal structures of the RNA-dependent RNA polymerase genotype 2a of hepatitis C virus (HCV) from two crystal forms have been determined. Similar to the three-dimensional structures of HCV polymerase genotype 1b and other known polymerases, the structures of the HCV polymerase genotype 2a in both crystal forms can be depicted in the classical right-hand arrangement with fingers, palm, and thumb domains. The main structural differences between the molecules in the two crystal forms lie at the interface of the fingers and thumb domains. The relative orientation of the thumb domain with respect to the fingers and palm domains and the beta-flap region is altered. Structural analysis reveals that the NS5B polymerase in crystal form I adopts a "closed" conformation that is believed to be the active form, whereas NS5B in crystal form II adopts an "open" conformation and is thus in the inactive form. In addition, we have determined the structures of two NS5B polymerase/non-nucleoside inhibitor complexes. Both inhibitors bind at a common binding site, which is nearly 35 A away from the polymerase active site and is located in the thumb domain. The binding pocket is predominantly hydrophobic in nature, and the enzyme inhibitor complexes are stabilized by hydrogen bonding and van der Waals interactions. Inhibitors can only be soaked in crystal form I and not in form II; examination of the enzyme-inhibitor complex reveals that the enzyme has undergone a dramatic conformational change from the form I (active) complex to the form II (inactive).

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 15746101     DOI: 10.1074/jbc.M413410200

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  78 in total

1.  Molecular mechanism of a thumb domain hepatitis C virus nonnucleoside RNA-dependent RNA polymerase inhibitor.

Authors:  Anita Y M Howe; Huiming Cheng; Ian Thompson; Srinivas K Chunduru; Steve Herrmann; John O'Connell; Atul Agarwal; Rajiv Chopra; Alfred M Del Vecchio
Journal:  Antimicrob Agents Chemother       Date:  2006-08-28       Impact factor: 5.191

2.  Step length measurement--theory and simulation for tethered bead constant-force single molecule assay.

Authors:  Anders E Wallin; Ari Salmi; Roman Tuma
Journal:  Biophys J       Date:  2007-05-11       Impact factor: 4.033

Review 3.  Structure-function relationships among RNA-dependent RNA polymerases.

Authors:  Kenneth K S Ng; Jamie J Arnold; Craig E Cameron
Journal:  Curr Top Microbiol Immunol       Date:  2008       Impact factor: 4.291

4.  Discovery of Novel Allosteric HCV NS5B Inhibitors. 2. Lactam-Containing Thiophene Carboxylates.

Authors:  Pan Li; Warren Dorsch; David J Lauffer; Darius Bilimoria; Nathalie Chauret; John J Court; Sanjoy Kumar Das; Francois Denis; Nagraj Mani; Suganthini Nanthakumar; Olivier Nicolas; B Govinda Rao; Steven Ronkin; Subajini Selliah; Rebecca S Shawgo; Ralph Stearns; Qing Tang; Nathan D Waal; Jeremy Green
Journal:  ACS Med Chem Lett       Date:  2017-01-31       Impact factor: 4.345

5.  Identification and functional characterization of the nascent RNA contacting residues of the hepatitis C virus RNA-dependent RNA polymerase.

Authors:  Robert Vaughan; Baochang Fan; Jin-Sam You; C Cheng Kao
Journal:  RNA       Date:  2012-06-26       Impact factor: 4.942

6.  Mutational evidence for a structural model of the Lassa virus RNA polymerase domain and identification of two residues, Gly1394 and Asp1395, that are critical for transcription but not replication of the genome.

Authors:  Meike Hass; Michaela Lelke; Carola Busch; Beate Becker-Ziaja; Stephan Günther
Journal:  J Virol       Date:  2008-07-30       Impact factor: 5.103

7.  A Modified P1 Moiety Enhances In Vitro Antiviral Activity against Various Multidrug-Resistant HIV-1 Variants and In Vitro Central Nervous System Penetration Properties of a Novel Nonpeptidic Protease Inhibitor, GRL-10413.

Authors:  Masayuki Amano; Pedro Miguel Salcedo-Gómez; Rui Zhao; Ravikiran S Yedidi; Debananda Das; Haydar Bulut; Nicole S Delino; Venkata Reddy Sheri; Arun K Ghosh; Hiroaki Mitsuya
Journal:  Antimicrob Agents Chemother       Date:  2016-11-21       Impact factor: 5.191

8.  Dynamics on multiple timescales in the RNA-directed RNA polymerase from the cystovirus phi6.

Authors:  Zhen Ren; Hsin Wang; Ranajeet Ghose
Journal:  Nucleic Acids Res       Date:  2010-04-12       Impact factor: 16.971

Review 9.  Hepatitis C: recent successes and continuing challenges in the development of improved treatment modalities.

Authors:  Tetsuro Shimakami; Robert E Lanford; Stanley M Lemon
Journal:  Curr Opin Pharmacol       Date:  2009-09-15       Impact factor: 5.547

10.  Binding-site identification and genotypic profiling of hepatitis C virus polymerase inhibitors.

Authors:  Frederik Pauwels; Wendy Mostmans; Ludo M M Quirynen; Liesbet van der Helm; Carlo W Boutton; Anne-Stéphanie Rueff; Erna Cleiren; Pierre Raboisson; Dominique Surleraux; Origène Nyanguile; Kenneth A Simmen
Journal:  J Virol       Date:  2007-04-25       Impact factor: 5.103

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.